EE9700093A - Apolipoproteiin-B sünteesi inhiibitorid - Google Patents

Apolipoproteiin-B sünteesi inhiibitorid

Info

Publication number
EE9700093A
EE9700093A EE9700093A EE9700093A EE9700093A EE 9700093 A EE9700093 A EE 9700093A EE 9700093 A EE9700093 A EE 9700093A EE 9700093 A EE9700093 A EE 9700093A EE 9700093 A EE9700093 A EE 9700093A
Authority
EE
Estonia
Prior art keywords
apolipoprotein
inhibitors
synthesis
Prior art date
Application number
EE9700093A
Other languages
English (en)
Other versions
EE04241B1 (et
Inventor
Jacobus Jozef Backx Leo
Alfons Leo Van Der Eycken Luc
Robert Guy Gabri�l De Chaffoy de Courcelles Didier
Heeres Jan
Jozef Maria Hendrickx Robert
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Priority claimed from PCT/EP1995/004111 external-priority patent/WO1996013499A1/en
Publication of EE9700093A publication Critical patent/EE9700093A/et
Publication of EE04241B1 publication Critical patent/EE04241B1/et

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
EE9700093A 1994-10-27 1995-10-19 Apolipoproteiin-B sünteesi inhibiitorid EE04241B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94203120 1994-10-27
PCT/EP1995/004111 WO1996013499A1 (en) 1994-10-27 1995-10-19 Apolipoprotein-b synthesis inhibitors

Publications (2)

Publication Number Publication Date
EE9700093A true EE9700093A (et) 1997-10-15
EE04241B1 EE04241B1 (et) 2004-02-16

Family

ID=8217315

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9700093A EE04241B1 (et) 1994-10-27 1995-10-19 Apolipoproteiin-B sünteesi inhibiitorid

Country Status (7)

Country Link
US (1) US5521186A (et)
EE (1) EE04241B1 (et)
MY (1) MY132062A (et)
PL (1) PL182432B1 (et)
RU (1) RU2144032C1 (et)
UA (1) UA58486C2 (et)
ZA (1) ZA959084B (et)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5703236A (en) * 1993-12-21 1997-12-30 Schering Corporation Tetrahydrofuran antifungals
DE69519995T2 (de) * 1994-10-27 2001-08-23 Janssen Pharmaceutica Nv Apolipoprotein-b syntheseinhibitoren
DE19638245A1 (de) * 1996-09-19 1998-03-26 Basf Ag Substituierte Carbamoyltriazole und ihre Verwendung als Herbizide
EP1028730B1 (en) * 1997-11-03 2002-04-17 Janssen Pharmaceutica N.V. Compositions of lipid lowering agents
US7649002B2 (en) 2004-02-04 2010-01-19 Pfizer Inc (3,5-dimethylpiperidin-1yl)(4-phenylpyrrolidin-3-yl)methanone derivatives as MCR4 agonists
US7262318B2 (en) * 2004-03-10 2007-08-28 Pfizer, Inc. Substituted heteroaryl- and phenylsulfamoyl compounds
US20050288340A1 (en) * 2004-06-29 2005-12-29 Pfizer Inc Substituted heteroaryl- and phenylsulfamoyl compounds
PA8660701A1 (es) 2005-02-04 2006-09-22 Pfizer Prod Inc Agonistas de pyy y sus usos
JP2008542255A (ja) * 2005-05-27 2008-11-27 ファイザー・プロダクツ・インク 肥満症の治療または体重減量の維持のためのカンナビノイド−1受容体アンタゴニストおよびミクロソームトリグリセリド輸送タンパク質阻害物質の併用
WO2007015162A1 (en) * 2005-08-04 2007-02-08 Pfizer Limited Piperidinoyl-pyrrolidine and piperidinoyl-piperidine compounds
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
ES2402581T3 (es) * 2006-02-23 2013-05-06 Pfizer Limited Piperidinoilpirrolidinas como agonistas del receptor de melanocortina tipo 4
US8383660B2 (en) 2006-03-10 2013-02-26 Pfizer Inc. Dibenzyl amine compounds and derivatives
MX2009004314A (es) 2006-11-13 2009-05-05 Pfizer Prod Inc Diaril, dipiridinil y arilpiridinilderivados y usos de los mismos.
CN101663262B (zh) 2006-12-01 2014-03-26 百时美施贵宝公司 用于治疗动脉粥样硬化和心血管疾病的作为cetp抑制剂的n-(3-苄基)-2,2-(二苯基)-丙-1胺衍生物
JP5530438B2 (ja) * 2008-08-06 2014-06-25 ファイザー・リミテッド Mc4作動薬としてのジアゼピンおよびジアゾカン化合物
EP3626242B1 (en) 2013-06-07 2024-08-07 The Scripps Research Institute Itraconazole analogs as inhibitors of fibrosis
JP6706023B2 (ja) * 2014-12-10 2020-06-03 ザ・スクリップス・リサーチ・インスティテュート 線維症の小分子阻害剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4267179A (en) * 1978-06-23 1981-05-12 Janssen Pharmaceutica, N.V. Heterocyclic derivatives of (4-phenylpiperazin-1-yl-aryloxymethyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles
CA1331757C (en) * 1988-02-29 1994-08-30 Janssen Pharmaceutica Naamloze Vennootschap 5-lipoxygenase inhibiting 4-(4-phenyl-1-piperazinyl)phenols
NZ233502A (en) * 1989-06-09 1991-11-26 Janssen Pharmaceutica Nv 4-(1,2,4-triazole- or imidazole-phenyl-substituted) -1-(1,3-dioxolan-4-ylmethoxyphenyl) piperazine derivatives; preparatory processes: fungicidal and antiviral compositions

Also Published As

Publication number Publication date
PL182432B1 (pl) 2002-01-31
MY132062A (en) 2007-09-28
RU2144032C1 (ru) 2000-01-10
US5521186A (en) 1996-05-28
PL319905A1 (en) 1997-09-01
EE04241B1 (et) 2004-02-16
UA58486C2 (uk) 2003-08-15
ZA959084B (en) 1997-04-29

Similar Documents

Publication Publication Date Title
FI971784A0 (fi) Apolipoproteiini B-synteesin estäjiä
FI963597L (fi) Isoprenyylitransferaasi-inhibiittoreita
NO972930D0 (no) Fibronectin-adhesjonsinhibitorer
FI972160A0 (fi) Matriisimetalloproteaasi-inhibiittorit
LV11178A (lv) 3-Ú4-(2-aminoetoksi) benzoil¾-2-aril-6-hidroksibenzoÚb¾tiofenu sintezes panemiens
FI20085256L (fi) Retrovirusperäisten proteaasi-inhibiittoreiden yhdistelmä
FI951553L (fi) 1H-indoli-glyoksyyliamidi-sPLA2-inhibiittoreita
DE69608448D1 (de) Reduktion des biobewuchses
IS4771A (is) Interlevkín-1ß umbreytiensím tálmar
FI941767A7 (fi) 1H-indoli-3-asetamidi sPLA2 inhibiittoreita
EE04241B1 (et) Apolipoproteiin-B sünteesi inhibiitorid
FI965019A7 (fi) Entsyymi-inhibiittoreita
ATE230275T1 (de) Angiogense-inhibitor
PT927183E (pt) Inibidores espirociclicos de metaloproteases
DE69531048D1 (de) Verwendung von steroidsulphatase-hemmern
FI945705A7 (fi) Bisindolyylimaleimidien parannettu synteesi
ID24270A (id) Penghilang sumbatan keratotik
NO990832D0 (no) Syntese av bisendolylmalimider
ID23437A (id) Penghilang sumbatan keratotik
IT1293320B1 (it) Miscela di stabilizzanti
BR9610514A (pt) Inibidores cicloantihelmínticos
FI963743L (fi) Reniini-inhibiittorien prototyyppien synteesi
CY2007006I1 (el) Αναστολεις συνθεσης απολιποπρωτεινης-β
KR950024188U (ko) 갈치주낚용 도래의 고정구
ID17328A (id) Pemurnian epsilon-kaprolaktam

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

AA1Y Spc filed

Free format text: PRODUCT NAME: YARVITAN - MITRATAPIID; REG NO/DATE: EU/2/06/063/001 14.11.2006 EU/2/06/063/002 14.11.2006 EU/2/06/063/003 14.11.2006

Spc suppl protection certif: C20070001

Filing date: 20070213

FG1Y Spc granted

Free format text: PRODUCT NAME: YARVITAN - MITRATAPIID; REG NO/DATE: EU/2/06/063/001 14.11.2006 EU/2/06/063/002 14.11.2006 EU/2/06/063/003 14.11.2006

Spc suppl protection certif: C20070001 00012

Filing date: 20070213

Extension date: 20201019

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20101231

GB1A Change in the ownership or in the address of the owner
MC1Y Annulment of an spc

Spc suppl protection certif: 00012

MM4A Lapsed by not paying the annual fees

Effective date: 20121019